Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Rubio

Showing results (281-290 of 320) with videos related to

Pageof 32
Sort By:
NPJ Breast Cancer|November 26, 2021
Neoadjuvant eribulin in HER2-negative early-stage breast cancer (SOLTI-1007-NeoEribulin): a multicenter, two-cohort, non-randomized phase II trialTomás Pascual, Mafalda Oliveira, Patricia Villagrasa, et al.
Breast (Edinburgh, Scotland)|September 20, 2024
Role of [<sup>18</sup>F]FDG PET/CT in patients with invasive breast carcinoma of no special type: Literature review and comparison between guidelinesDavid Groheux, Sofia C Vaz, Philip Poortmans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2025
[<sup>18</sup>F]-Labeled Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Staging and Restaging Patients With Breast CancerDavid Groheux, Sofia C Vaz, Lioe-Fee de Geus-Oei, et al.
Plos One|June 16, 2015
Patterns of HER2 Gene Amplification and Response to Anti-HER2 TherapiesRocio Vicario, Vicente Peg, Beatriz Morancho, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 16, 2019
European Society of Surgical Oncology's strategy for clinical research: Paving the way for a culture of research in cancer surgeryS Evrard, C van de Velde, I Noordhoek, et al.
The British Journal of Dermatology|January 11, 2014
Skin ulcers related to chronic graft-versus-host disease: clinical findings and associated morbidityM Jachiet, A de Masson, R Peffault de Latour, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 13, 2024
Joint EANM-SNMMI guideline on the role of 2-[<sup>18</sup>F]FDG PET/CT in no special type breast cancer : (endorsed by the ACR, ESSO, ESTRO, EUSOBI/ESR, and EUSOMA)Sofia C Vaz, John Patrick Pilkington Woll, Fatima Cardoso, et al.
Cancer Discovery|August 24, 2012
PI3K inhibition impairs BRCA1/2 expression and sensitizes BRCA-proficient triple-negative breast cancer to PARP inhibitionYasir H Ibrahim, Celina García-García, Violeta Serra, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 15, 2024
A multidisciplinary team and patient perspective on omission of surgery after neoadjuvant systemic therapy for early breast cancer: A European Society of Surgical Oncology (ESSO) Research Academy surveyCarmela Caballero, Dara J Lundon, Mariela Vasileva-Slaveva, et al.
NPJ Breast Cancer|June 8, 2021
The temporal mutational and immune tumour microenvironment remodelling of HER2-negative primary breast cancersLeticia De Mattos-Arruda, Javier Cortes, Juan Blanco-Heredia, et al.
Pageof 32

Showing results (281-290 of 320) with videos related to

Sort By:
Pageof 32
NPJ Breast Cancer|November 26, 2021
Neoadjuvant eribulin in HER2-negative early-stage breast cancer (SOLTI-1007-NeoEribulin): a multicenter, two-cohort, non-randomized phase II trialTomás Pascual, Mafalda Oliveira, Patricia Villagrasa, et al.
Breast (Edinburgh, Scotland)|September 20, 2024
Role of [<sup>18</sup>F]FDG PET/CT in patients with invasive breast carcinoma of no special type: Literature review and comparison between guidelinesDavid Groheux, Sofia C Vaz, Philip Poortmans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2025
[<sup>18</sup>F]-Labeled Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Staging and Restaging Patients With Breast CancerDavid Groheux, Sofia C Vaz, Lioe-Fee de Geus-Oei, et al.
Plos One|June 16, 2015
Patterns of HER2 Gene Amplification and Response to Anti-HER2 TherapiesRocio Vicario, Vicente Peg, Beatriz Morancho, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 16, 2019
European Society of Surgical Oncology's strategy for clinical research: Paving the way for a culture of research in cancer surgeryS Evrard, C van de Velde, I Noordhoek, et al.
The British Journal of Dermatology|January 11, 2014
Skin ulcers related to chronic graft-versus-host disease: clinical findings and associated morbidityM Jachiet, A de Masson, R Peffault de Latour, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 13, 2024
Joint EANM-SNMMI guideline on the role of 2-[<sup>18</sup>F]FDG PET/CT in no special type breast cancer : (endorsed by the ACR, ESSO, ESTRO, EUSOBI/ESR, and EUSOMA)Sofia C Vaz, John Patrick Pilkington Woll, Fatima Cardoso, et al.
Cancer Discovery|August 24, 2012
PI3K inhibition impairs BRCA1/2 expression and sensitizes BRCA-proficient triple-negative breast cancer to PARP inhibitionYasir H Ibrahim, Celina García-García, Violeta Serra, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 15, 2024
A multidisciplinary team and patient perspective on omission of surgery after neoadjuvant systemic therapy for early breast cancer: A European Society of Surgical Oncology (ESSO) Research Academy surveyCarmela Caballero, Dara J Lundon, Mariela Vasileva-Slaveva, et al.
NPJ Breast Cancer|June 8, 2021
The temporal mutational and immune tumour microenvironment remodelling of HER2-negative primary breast cancersLeticia De Mattos-Arruda, Javier Cortes, Juan Blanco-Heredia, et al.
Pageof 32